Objectives: In 2009, the annual incidence of positive human immunodeficiency virus (HIV) test reports for people in the Saskatoon Health Region (SHR) was 31.3 per 100 000, when the national average was only 9.3 per 100 000. The first objective was to determine the prevalence of depressive symptomatology among injection drug users (IDUs) in the SHR. The second objective was to determine the unadjusted and adjusted risk indicators associated with depressive symptomatology among IDUs. The third objective was to determine if depressive symptomatology was associated with HIV risk behaviours. , 603 current IDUs were surveyed with validated instruments; this sample represents 76.6% of known IDUs in the SHR.
T he number of new positive HIV test reports in the SHR in the province of Saskatchewan is rapidly on the rise. In 2004, there were 16 positive test reports confirmed, which increased annually to 39 in 2005, 53 in 2006, 57 in 2007, 77 in 2008, and 94 in 2009 . In 2009, the annual incidence of positive HIV test reports for people in the SHR was 31.3 per 100 000, when the national average was only 9.3 per 100 000. 1 Detailed information on HIV risk indicators for the SHR is unavailable, but it is available for the province of Saskatchewan, where the SHR had 54% of all new infections in 2008. 2 The majority (76.9%) of positive HIV test reports in the province were associated with injection drug use, compared with 18.9% nationally. 1, 2 Depression among IDUs is associated with increased risk behaviours, and there are numerous papers that support this. 3 For example, Perdue et al 3 found that depression was associated with an increased likelihood of injecting with a syringe that had been used by another IDU. Latkin and Mandell 4 reported that depression was highly correlated with increased injection drug use frequency. Simpson et al 5 found that depression was associated with syringe sharing and injection equipment sharing. Finally, Mandell et al 6 reported that depressive symptoms were associated with needle sharing among IDUs.
Therefore, if depression is associated with HIV risk behaviour, how prevalent is depressive symptomatology among IDUs? The prevalence estimates available differ based on the diagnostic method used (diagnostic interview or dimensional instrument), the dimensional instrument used, and the cut-off value used. Perdue et al 3 used the CES-D, with a cut-off value of equal to or greater than 23, and found a point prevalence of 46.9%. Two other studies 7, 8 used the CES-D, with a cut-off value of equal to or greater than 16, and found a point prevalence of 52.6% and 38%. Using the BDI-II, Johnson et al 9 found that 51.3% reported minimal depression, 18.6% reported moderate depression, and 13.6% reported severe depression. Finally, Lipsitz et al 10 used the SCID-III-R and found that 26% had a current diagnosis of depression. Although diagnostic methods, instruments, and cut-off values explain most of the wide variance in point prevalence, a portion of the variance could also be explained by differences in the IDUs and sampling methodology, the cities they live in, and the health and social services available to them.
The first objective was to determine the prevalence of depressive symptomatology within IDUs in the SHR. The second objective was to determine the unadjusted and adjusted risk indicators associated with depressive symptomatology within IDUs in the SHR. The third objective was to determine if depressive symptomatology was associated with HIV risk behaviours. The fourth objective was to determine barriers to care within IDUs.
Methods
The research was conducted by the Saskatoon Tribal Council and the University of Saskatchewan's School of Public Health.
From September 2009 to April 2010, Saskatoon residents that were either a current IDU, a current sex trade worker, a person that frequently used the services of a sex trade worker, or a man who had sex with other men were recruited to participate in the study survey. The location sites included a primary care clinic within Saskatoon's lowincome neighbourhoods, a needle exchange van operated by the SHR, a needle exchange and primary care facility operated by the Saskatoon Tribal Council, AIDS Saskatoon, and a facility that offers free meals within Saskatoon's lowincome neighbourhoods. Respondents were given $20 for participating in the survey. Only adults aged 18 years and older participated and were required to give written and informed consent. Ethics approval was obtained from the University of Saskatchewan Behavioural Research Ethics Board (BEH# 08-53).
The survey used consisted of 175 questions taken from validated questionnaires used to measure demographics, SES, depressive symptomatology, significant life events, HIV risk behaviours, and barriers to services.
Before starting the study, the SHR published a report indicating that public health services had contact with 787 IDUs within the SHR in the past year. 11 As such, an attempt would be made to interview up to 787 IDUs with an overall sample size of 1000, which would include other risk groups, such as sex trade workers. The RBA Questionnaire developed by the National Institute on Drug Abuse was used to ask the question "Have you injected a drug in the last 4 weeks?" If the respondent answered yes, the respondent was accepted as a current IDU. The kappa coefficient for this question has a range between 0.63 and 0.66. 12 Questions on demographics and SES were also taken from the RBA Questionnaire. to as VIDUS). 13, 14 The reliability of the survey regarding IDUs self-reporting SES has a kappa coefficient ranging from 0.78 to 1.00. 15 The CES-D was used to measure depressive symptomatology. The scale consists of 20 questions about mood and behaviours within the last 7 days in which the participant answers using a 4-point Likert scale, with 1 meaning rarely or none of the time (less than 1 day), 2 meaning some or a little of the time (1 to 2 days), 3 meaning occasionally or a moderate amount of the time (3 to 4 days), and 4 meaning most or all of the time (5 to 7 days).
The CES-D has been used both in community and in clinical populations and has even been used specifically with IDUs. 3, 7, 8 The CES-D has been found to be valid and reliable, with Cronbach's alpha of equal to or greater than 0.92, among adults who are IDUs. 8 A summary score of equal to or greater than 16 has been used most often as a cut-off for depressive symptomatology, but one study 3 suggests using a cut-off of 23 or higher to reduce the number of false positives. As such, our study will initially report the point prevalence for both cut-offs, although the value of equal to or greater than 16 will be used for all additional analysis.
Aboriginal cultural status was defined as someone who selfidentified as First Nations, Métis, or Inuit. The remaining cultural groups were Caucasian or Other. In the SHR, the 2006 Census reports that 85.1% of the population is Caucasian, whereas 9.2% is Aboriginal. 16 Questions measuring the prevalence of significant life events were taken from the HIV/AIDS Questionnaire. 17 This survey contains a checklist of 11 different traumatic events. In addition, 2 questions were added by the research team to determine if the respondent attended a residential school, or if they had a parent or grandparent who had attended a residential school.
The RBA Questionnaire was also used to determine whether a participant had ever traded sex for drugs, traded sex for money, or traded drugs for sex. The Spearman correlations (r s ) for these questions are 0.66, 0.72, and 0.78, respectively. 18 Questions asking how many times participants injected in the last 30 days, and with how many used syringes, also came from this questionnaire. The Pearson product-moment correlations (r) for these questions were 0.88 and 0.85, respectively. 18 Questions regarding drug treatment and detox programs also came from the RBA, with test-retest reliability ranging from 0.67 to 0.86. 19 The Barriers to Care Scale was used to assess participants' barriers to services. The coefficient alpha for the entire scale is 0.86. It also contains 4 subscales, including geography and distance (0.73), medical and psychological service (0.74), community stigma (0.73), and personal resources (0.78). 21 Cross-tabulations were performed, using SPSS 18 statistical software (SPSS Inc, Chicago, IL), with chi-square tests initially between demographics, SES, and significant life events by depressed mood among IDUs. After these initial cross-tabulations, hierarchal well-formulated binary logistic regression was used to determine the association between the outcome variable of being an IDU with depressive symptomatology (compared with no depressive symptomatology) and all potential explanatory variables. The unadjusted effect of each covariate was determined and then entered, one step at a time, based on changes in the -2 log likelihood and the Wald test. 22 The final results are presented as adjusted odds ratios with 95% confidence intervals.
Cross-tabulations were then computed for HIV risk behaviours by depressive symptomatology, and for barriers to care by depressive symptomatology listed by IDUs. After these initial cross-tabulations, binary logistic regression was used to determine the association between HIV risk behaviours and depressive symptomatology among IDUs.
Owing to space limitations, only statistically significant associations appear in the tables (Tables 1 to 5 ). The regression models in Tables 3 and 5 are only adjusted for the covariates listed in the tables. 
Results
One thousand people who were at risk of testing positive for HIV were interviewed during a 6-month period. Thirty interviews had a high likelihood of duplication and were therefore removed, for a total sample of 970 surveys. This included 603 participants who qualified as a current IDU. This sample represents 76.6% of the known IDUs in the city of Saskatoon and forms the sample for our study.
From a demographic point of view, IDUs were more likely to be male, with the most common age group being aged 30 to 39 years. Most of the respondents were single and 88.1% of the IDUs self-identified as Aboriginal (Table 1) .
From a SES point of view, most of the IDUs had not graduated from high school (74%) and lived in someone else's home or apartment (44.9%), while 34.5% considered themselves homeless. The majority were unemployed (54.4%) or were on some form of disability insurance or social assistance (24.4%). Most of the respondents had an annual household income that ranged between $0 and $9999 (62.4%), with the average being $8474 (data not shown).
Using the CES-D with a cut-off score of equal to or greater than 16, 81.4% of the respondents qualified as having depressive symptomatology. Using the CES-D with a cutoff score of 23 or higher, 57.7% of the respondents had more severe depressive symptomatology.
Using the cut-off score of 16 to define depressive symptomatology, cross-tabulations were calculated with demographics, SES, and significant life events. Statistically significant associations with depressive symptomatology were found for being female, being homeless, having an annual income below $10 000, and 8 significant life events ( Table 2) . Nonsignificant associations included age, marital status, cultural status, education level, living arrangements, employment status, and sources of income (data not shown).
Statistically significant life events associated with depressive symptomatology included physical assault or abuse in adult life by a partner, physical assault or abuse in adult life by someone other than a partner, witnessing violence in the home as a child, sexual assault as an adult, sexual assault as a child, death or permanent separation from a parent or someone like a parent as a child, and attending a residential school or having had a parent or grandparent who had attended a residential school ( Table 2) . Nonsignificant life events are not listed or shown.
After cross-tabulation, 11 variables had an unadjusted association with depressive symptomatology. Binary logistic regression was used to determine the adjusted association between the outcome variable of being an IDU with depressive symptomatology (compared with no depressive symptomatology) and the potential explanatory variables. The 4 covariates with an independent association with depressive symptomatology include sexual assault as an adult, sexual assault as a child, attending a residential school, and having an annual income below $10 000 (Table 3) .
Cross-tabulations were computed for HIV risk behaviours by depressive symptomatology. Table 4 lists 7 risk behaviours that are more common when IDUs have depressive symptomatology. The risk behaviours include giving sex to get money, giving sex to get drugs, giving drugs to get sex, more frequent sharing of injecting equipment in general, more frequent loaning of used needles to friends or acquaintances, more frequently injecting with needles used by a sexual partner, and more frequently injecting with needles used by a friend or acquaintance. Only statistically significant associations are listed within the table. After logistic regression, only giving sex to get money, giving drugs to get sex, and frequently or sometimes sharing injecting equipment were associated with depressive symptomatology ( Table 5 ).
Statistically significant barriers to care by depressive symptomatology include problems with long distances to medical facilities (60.1% with depressive symptomatology list this as a problem, compared with 48.3% of those without depressive symptomatology), lack of transportation (75.7% to 57.1%), medical personnel who decline to provide direct 
Discussion
In our study, 81.4% of the IDUs had depressive symptomatology (CES-D cut-off value of equal to or greater than 16), while 57.7% reported more severe depressive symptomatology (CES-D cut-off value of equal to or greater than 23). In previous studies using the CES-D with a cutoff value of 16, depressive symptomatology ranged from 38% to 52.6% of IDUs. 7, 8 In a previous study 3 using the CES-D with a cut-off value of 23, more severe depressive symptomatology was found in 46.9% of IDUs. Regardless of cut-off value, the rates of depressive symptomatology observed among IDUs in our study are higher than those reported in the literature.
Before statistical adjustment, 11 variables had an association with depressive symptomatology. After multivariate regression analysis, the 4 covariates with an independent association with depressive symptomatology included sexual assault as an adult, sexual assault as a child, attending a residential school, and having an annual income below $10 000.
Previous studies [23] [24] [25] have found associations between injection drug use and previous sexual abuse, and attending a residential school and poverty. Our study adds to the literature by finding that these variables are associated with depressive symptomatology among IDUs. This finding has 2 implications. First, we need to integrate substance abuse prevention and cessation efforts with postvictimization services. 23 Second, we need broad public policy initiatives, such as increased payments from Social Services and subsidized housing, to prevent poverty among IDUs, which will help to reduce depressive symptomatology. 25 Our finding that 7 HIV risk behaviours were more common among IDUs with depressive symptomatology is consistent with the literature. Our study, along with previous studies, [3] [4] [5] [6] found that depressive symptomatology was associated with more frequently sharing equipment or injecting with needles used by friends, acquaintances, and sexual partners. A new finding is that depressive symptomatology was associated with giving sex to get money, giving sex to get drugs, or giving drugs to get sex. Inconsistent with one study, 4 our study did not find that depressive symptomatology was associated with increased injection drug use frequency. After logistic regression, only giving sex to get money, giving drugs to get sex and frequently, or sometimes sharing injecting equipment were independently associated with depressive symptomatology.
Our study also asked about self-report barriers to accessing care. Barriers to care significantly associated with depressive symptomatology included long distances to medical facilities, lack of transportation to these far away facilities, medical personnel who decline to provide direct care, shortages of mental health personnel to address mental health problems, and being unable to access drug treatment programs owing mainly to long waiting lists.
These barriers to care are regrettable for 2 reasons. First, a prospective longitudinal study 8 on predictors of depressive symptoms among low-income IDUs found that quitting drug use was associated with reduced depressive symptoms at follow-up. The authors of this study 8 conclude that facilitating drug treatment and preventative medical care in reducing depression in this high-risk population is a key public health priority. Second, depression has been identified as a condition that increases HIV risk behaviours in our study and in other studies. [3] [4] [5] [6] In other words, we need to offer more services where IDUs live, and these services require compassionate mental health providers who treat both depression and drug abuse as a means to reduce HIV risk behaviour, which will hopefully reduce HIV incidence.
There are 3 study limitations to discuss. The main limitation is that our study was cross-sectional and therefore unable to determine causation. Although validated surveys were used, all of the information generated was based on selfreport information. No attempt was made to validate the information provided. Even though our sample represented 76.6% of the known IDUs in Saskatoon, no attempt was made to collect information from the remaining 23.4% to determine if they were different from the study sample.
Conclusions
The number of new positive HIV test reports in the SHR is on the rise. In 2009, the annual incidence of positive HIV test reports for people in the SHR was 31.3 per 100 000, when the national average was only 9.3 per 100 000. 1 Our study suggests that there are high rates of depressive symptomatology among IDUs in the SHR and that depressive symptomatology is associated with HIV risk behaviours. The 4 covariates with an independent association with depressive symptomatology included sexual assault as an adult, sexual assault as a child, attending a residential school, and having an annual income below $10 000. The 3 risk behaviour covariates, with an independent association with depressive symptomatology, included giving sex to get money, giving drugs to get sex, and frequently or sometimes sharing injecting equipment.
